QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
Log in
NASDAQ:MNTA

Momenta Pharmaceuticals SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
$52.48
0.00 (0.00 %)
(As of 10/2/2020)
Add
Compare
Today's Range
$52.48
Now: $52.48
$52.48
50-Day Range
$52.26
MA: $52.44
$52.49
52-Week Range
$12.21
Now: $52.48
$52.53
VolumeN/A
Average Volume1.94 million shs
Market Capitalization$6.25 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.71

SEC Filings

Momenta Pharmaceuticals (NASDAQ:MNTA) SEC Filings

DateFilerForm TypeView
11/10/2020
9:27 AM
FMR LLC (Filed by)
Momenta Pharmaceuticals (Subject)
Form SC 13G/A
10/13/2020
7:15 AM
Momenta Pharmaceuticals (Filer)
Form 15-12G
10/01/2020
4:18 PM
Momenta Pharmaceuticals (Issuer)
Momenta Pharmaceuticals (Issuer)
Stoner Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
4:17 PM
Momenta Pharmaceuticals (Issuer)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
4:15 PM
GROGAN DONNA ROY (Reporting)
Momenta Pharmaceuticals (Issuer)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
4:14 PM
Momenta Pharmaceuticals (Issuer)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
4:12 PM
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
4:10 PM
DOWNEY BRUCE (Reporting)
DOWNEY BRUCE (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
4:08 PM
Barlow Jane F (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
4:07 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
4:05 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
4:03 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
4:01 PM
Cieplinska Agnieszka (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
4:00 PM
Carvajal Alejandra (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
3:58 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
3:56 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
3:49 PM
Momenta Pharmaceuticals (Filer)
Form S-8 POS
10/01/2020
3:48 PM
Momenta Pharmaceuticals (Filer)
Form S-8 POS
10/01/2020
3:47 PM
Momenta Pharmaceuticals (Filer)
Form S-8 POS
10/01/2020
3:46 PM
Momenta Pharmaceuticals (Filer)
Form S-8 POS
10/01/2020
3:45 PM
Momenta Pharmaceuticals (Filer)
Form S-8 POS
10/01/2020
3:44 PM
Momenta Pharmaceuticals (Filer)
Form S-8 POS
10/01/2020
3:44 PM
Momenta Pharmaceuticals (Filer)
Form S-8 POS
10/01/2020
3:42 PM
Momenta Pharmaceuticals (Filer)
Form S-8 POS
10/01/2020
3:41 PM
Momenta Pharmaceuticals (Filer)
Form S-8 POS
10/01/2020
3:21 PM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2020
8:55 AM
Momenta Pharmaceuticals (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
10/01/2020
7:59 AM
JOHNSON & JOHNSON (Filed by)
Momenta Pharmaceuticals (Subject)
Form SC TO-T/A
10/01/2020
7:56 AM
Momenta Pharmaceuticals (Subject)
Form SC 14D9/A
09/23/2020
3:48 PM
JOHNSON & JOHNSON (Filed by)
Momenta Pharmaceuticals (Subject)
Form SC TO-T/A
09/23/2020
3:45 PM
Momenta Pharmaceuticals (Subject)
Form SC 14D9/A
09/15/2020
3:34 PM
JOHNSON & JOHNSON (Filed by)
Momenta Pharmaceuticals (Subject)
Form SC TO-T/A
09/15/2020
3:05 PM
Momenta Pharmaceuticals (Subject)
Form SC 14D9/A
09/04/2020
4:08 PM
JOHNSON & JOHNSON (Filed by)
Momenta Pharmaceuticals (Subject)
Form SC TO-T/A
09/04/2020
4:03 PM
Momenta Pharmaceuticals (Subject)
Form SC 14D9/A
09/02/2020
5:54 AM
Momenta Pharmaceuticals (Subject)
Form SC 14D9
09/02/2020
5:46 AM
JOHNSON & JOHNSON (Filed by)
Momenta Pharmaceuticals (Subject)
Form SC TO-T
08/21/2020
3:55 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
5:19 PM
Gutierrez-Ramos Jose-Carlos (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
2:17 PM
JOHNSON & JOHNSON (Filed by)
Momenta Pharmaceuticals (Subject)
Form SC TO-C
08/19/2020
3:31 PM
JOHNSON & JOHNSON (Filed by)
Momenta Pharmaceuticals (Subject)
Form SC TO-C
08/19/2020
3:25 PM
Momenta Pharmaceuticals (Subject)
Form SC14D9C
08/19/2020
6:27 AM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2020
6:46 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
4:47 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
3:42 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
3:41 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
3:41 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
3:40 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
3:40 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
7:05 AM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2020
4:04 PM
GILMAN STEVEN C (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
3:48 PM
GEMAYEL GEORGES (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
3:19 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
3:18 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2020
6:29 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2020
6:03 PM
GEMAYEL GEORGES (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2020
6:03 PM
GILMAN STEVEN C (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2020
4:24 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2020
4:14 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2020
4:55 PM
GILMAN STEVEN C (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2020
4:42 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2020
3:08 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2020
3:07 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
3:03 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
3:03 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
3:02 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
3:02 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2020
3:28 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2020
4:54 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
8:16 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
8:15 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
8:15 PM
Cieplinska Agnieszka (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
8:15 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
8:14 PM
Carvajal Alejandra (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
8:14 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
8:14 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
8:13 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
4:47 PM
DOWNEY BRUCE (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
4:46 PM
GILMAN STEVEN C (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
4:46 PM
GEMAYEL GEORGES (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
4:46 PM
Gutierrez-Ramos Jose-Carlos (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
4:45 PM
Momenta Pharmaceuticals (Issuer)
Stoner Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
4:45 PM
Barlow Jane F (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
4:45 PM
GROGAN DONNA ROY (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
3:06 PM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
4:32 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
4:29 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
4:27 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
4:26 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
4:25 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
4:25 PM
Carvajal Alejandra (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
4:24 PM
Cieplinska Agnieszka (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
4:21 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:07 AM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2020
4:51 PM
DOWNEY BRUCE (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
4:06 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
3:34 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
5:04 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
3:49 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.